|
![]() |
|||
|
||||
OverviewContains 12 relevant, practice-oriented topics including theragnostics trials; neuroendocrine tumors: diagnostics; prostate-specific membrane antigen: diagnostics; theragnostics: post-therapy imaging; fibroblast-activation-protein inhibitors (FAPI) theragnostics; and more. Provides in-depth clinical reviews on theragnostics, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. In this issue of PET Clinics, guest editors Drs. Andrei Iagaru and Heather A. Jacene bring their considerable expertise to the topic of Theragnostics. Top experts in the field discuss neuroendocrine tumors: beta-labeled peptides; prostate-specific membrane antigen: interpretation criteria, standardized reporting and the use of artificial intelligence; prostate cancer (gastrin-releasing peptide receptor); selective internal radiation therapy; future directions in theragnostics; and more. Full Product DetailsAuthor: Andrei Iagaru (Nuclear Medicine, Stanford, CA, USA) , Heather A. Jacene, MD (Department of Radiology<br>Brigham and Women's Hospital<br>Harvard Medical School)Publisher: Elsevier Health Sciences Imprint: Churchill Livingstone Weight: 0.450kg ISBN: 9780443129216ISBN 10: 0443129215 Pages: 240 Publication Date: 06 June 2024 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |